Synthesis of low molecular weight compounds with complement inhibition activity

Area of Science:

• Medicinal Chemistry
• Immunology
• Biochemistry

Background:

• The human complement system plays a crucial role in innate immunity.
• Modulating complement activation is a therapeutic target for various immune and inflammatory diseases.
• Aromatic ethers represent a class of compounds with potential biological activities.

Purpose of the Study:

• To synthesize novel non-cytotoxic, low molecular weight meta-substituted aromatic ethers and their bioisosteres.
• To evaluate the synthesized compounds for their activity in inhibiting human complement (classical pathway) activation.
• To assess the intrinsic hemolytic activity of these compounds.

Main Methods:

• Chemical synthesis of meta-substituted aromatic ethers and their bioisosteres.
• In vitro assays to measure inhibition of complement-mediated hemolysis.
• Evaluation of intrinsic hemolytic activity of the synthesized analogues.

Main Results:

• Aldehydic meta-substituted aromatic ethers demonstrated significant inhibitory potency against complement activation.
• Carboxylic acid meta-substituted aromatic ethers exhibited notable hemolytic activity.
• Certain bioisosteres displayed a dual property, showing both complement inhibition and hemolytic activity.

Conclusions:

• Meta-substituted aromatic ethers can modulate human complement activation.
• The functional group (aldehyde vs. carboxylic acid) dictates the compound's primary activity (inhibition vs. hemolysis).
• Bioisosteric modifications offer potential for developing compounds with tailored complement-modulating properties.